Market Size of Johne's Disease Diagnostics Industry
| Study Period | 2021 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.10 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Johne's Disease Diagnostics Market Analysis
The Johne's disease diagnostics market is expected to register a CAGR of 5.10% over the forecast period.
The COVID-19 pandemic resulted in a decline in the market for Johne's disease diagnostics. This negative impact is due to the closure of and restricted access to veterinary diagnostics due to lockdown and social distancing norms. For instance, in April 2022, an article published by the Indian Journals of Animal Science showed a significant decline in the number of hospital cases attended by veterinarians, with a major decline in pets (54.9%), followed by goats (35.3%), and sheep (29%) being observed during the lockdown. However, the demand steadily recovered as governments started to relax their stay-at-home policies. Inefficiencies in field testing and remote collaboration were other challenges brought on by the COVID-19 pandemic. Over the forecast period, the market for Johne's disease diagnostics is estimated to grow notably, owing to the rising demand for rapid and easy diagnostic products and comparatively lax regulatory supervision. The US FDA does not mandate that manufacturers who exclusively market or manufacture veterinary devices list their devices or register their establishments. Thus, the pandemic has had a profound impact on the market.
The increase in animal health and diagnostics companies, the increase in veterinary healthcare expenditure, and increased awareness about paratuberculosis and Johne's disease eradication programs are some of the growth factors driving market growth.
Furthermore, the market growth for Johne's disease diagnostics is being supported by constant innovation in the veterinary diagnostics sector. For instance, Zoetis announced the addition of digital cytology testing to their VETSCAN IMAGYST platform, which was introduced in September 2020 and March 2022. VETSCAN IMAGYST provides access to a network of remote professional clinical diagnosticians as well as AI technologies for fecal testing. Additionally,
In April 2022, PDB Biotech launched Johne's disease testing services. PDB Biotech's new quick testing service will allow farmers to determine in days whether bulk milk or blood samples contain Mycobacterium avium subspecies paratuberculosis (MAP), the organism that causes Johne's disease. To identify the presence of live mycobacteria in a sample of blood or bulk milk, the service uses the diagnostic test Actiphage.
Moreover, increasing awareness regarding tuberculosis and vaccination programs is also propelling the growth of the market. For instance, the United States Department of Agriculture's (USDA) Animal and Plant Health Inspection Service's Veterinary Services department (USDA-APHIS-VS) has developed a Johne's disease curb program for preventing the spread of the disease to non-infected herds. It has developed a cooperative federal-state-industry program for providing producer assistance by performing risk assessments. It is also working on providing funding for research for the development and validation of control measures.
Furthermore, veterinary medicine has historically outperformed human treatment in terms of diagnostic results and client calls returned. In-clinic digital cytology scanners from IDEXX and Antech are now advancing the industry's development and productivity by providing quick results, improving client adherence and happiness, and connecting veterinarians to pathologists. Therefore, owing to the aforementioned factors, it is anticipated that the studied market will witness growth over the analysis period.
